Literature DB >> 24458320

Development of a prediction formula of Parkinson disease severity by optical coherence tomography.

Beatriz Jiménez1, Francisco J Ascaso, José A Cristóbal, Javier López del Val.   

Abstract

The aims of this study were to assess the peripapillary retinal nerve fiber layer (RNFL) thickness in patients with Parkinson's disease (PD), to determine its correlation with disease severity, and to define a simple biomarker for predicting clinical severity. One hundred two eyes from 52 patients affected by PD were compared with 97 eyes from 50 age-comparable controls. In all patients, peripapillary RNFL thickness was measured by optical coherence tomography (OCT). We used the Unified Parkinson's Disease Rating Scale (UPDRS) total score and measured responses in the on medication state. Eyes from patients with PD had a statistically significant decrease in average peripapillary RNFL thickness compared with control eyes (P < 0.001). This reduction was observed in every quadrant (inferior, superior, nasal [P < 0.001], and temporal [P = 0.017]) in patients with PD. Furthermore, a strong inverse correlation was found between the PD severity measured according to the UPDRS score and the average peripapillary RNFL thickness (r = -0.615; P < 0.001) and PD duration (r = -0.303; P = 0.002). From these results, we defined a regression equation that predicts the UPDRS score from the above-mentioned variables: UPDRS = 81.6 + 29.6 * log PD duration (years) - 0.6 * RFNL thickness (μm). We observed that, as the evolution and severity of PD progress, the peripapillary RNFL layer thickness, as evaluated by OCT, gradually diminishes. These results suggest that the average peripapillary RNFL thickness measured by OCT might be useful as a biomarker to detect the early onset and progression of PD.
Copyright © 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; Unified Parkinson's Disease Rating Scale; disease duration; optical coherence tomography; retinal nerve fiber layer thickness

Mesh:

Year:  2013        PMID: 24458320     DOI: 10.1002/mds.25747

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis.

Authors:  Vedat Cilingir; Muhammed Batur; Mehmet Deniz Bulut; Aysel Milanlioglu; Abdullah Yılgor; Abdussamet Batur; Tekin Yasar; Temel Tombul
Journal:  Neurol Sci       Date:  2017-04-10       Impact factor: 3.307

2.  Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

Authors:  B Hanna-Pladdy; R Pahwa; K E Lyons
Journal:  Cereb Cortex Commun       Date:  2021-06-24

Review 3.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

4.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.

Authors:  Shounak Baksi; Ajai K Tripathi; Neena Singh
Journal:  Free Radic Biol Med       Date:  2016-06-23       Impact factor: 7.376

Review 5.  Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.

Authors:  Thein Than Htike; Sachin Mishra; Sundramurthy Kumar; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2018-07-14       Impact factor: 5.590

6.  Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.

Authors:  Zi-Jiao Yang; Jing Wei; Cheng-Jie Mao; Jin-Ru Zhang; Jing Chen; Xiao-Yan Ji; Jun-Yi Liu; Yun Shen; Kang-Ping Xiong; Jun-Ying Huang; Ya-Ping Yang; Chun-Feng Liu
Journal:  Sleep Breath       Date:  2016-06-03       Impact factor: 2.816

Review 7.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 8.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

9.  The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.

Authors:  Eduardo Maria Normando; Benjamin Michael Davis; Lies De Groef; Shereen Nizari; Lisa A Turner; Nivedita Ravindran; Milena Pahlitzsch; Jonathan Brenton; Giulia Malaguarnera; Li Guo; Satyanarayana Somavarapu; Maria Francesca Cordeiro
Journal:  Acta Neuropathol Commun       Date:  2016-08-18       Impact factor: 7.801

10.  Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography.

Authors:  Robert Kromer; Carsten Buhmann; Ute Hidding; Matthias Keserü; Diana Keserü; Andrea Hassenstein; Birthe Stemplewitz
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.